Tevogen Bio Holdings Inc.
TVGN
$1.08
$0.088.00%
| Weiss Ratings | TVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | TVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.10 | |||
| Price History | TVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.93% | |||
| 30-Day Total Return | -15.63% | |||
| 60-Day Total Return | -13.60% | |||
| 90-Day Total Return | -17.56% | |||
| Year to Date Total Return | 1.89% | |||
| 1-Year Total Return | -56.28% | |||
| 2-Year Total Return | -89.99% | |||
| 3-Year Total Return | -89.20% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -67.64% | |||
| 52-Week Low % Change | 291.24% | |||
| Price | TVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.09 | |||
| 52-Week Low Price | $0.26 | |||
| 52-Week Low Price (Date) | Oct 09, 2024 | |||
| 52-Week High Price (Date) | Oct 25, 2024 | |||
| Valuation | TVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 183.89M | |||
| Enterprise Value | 194.30M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.09 | |||
| Earnings Per Share Growth | -86.07% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -11.51 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $1.08 | |||
| Enterprise Value/EBITDA (TTM) | -3.64 | |||
| Enterprise Value/EBIT | -3.63 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | TVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 106.69M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 877 838 6434 | |||
| Address | 15 Independence Boulevard Warren, NJ 07059 | |||
| Website | tevogen.com | |||
| Country | United States | |||
| Year Founded | 2020 | |||
| Profitability | TVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | TVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -746.67% | |||
| Return on Equity | -- | |||
| Income Statement | TVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -53.40M | |||
| EBIT (TTM) | -53.56M | |||
| Net Income (TTM) | -13.73M | |||
| Net Income Avl. to Common (TTM) | -13.73M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -160.02% | |||
| EPS Diluted (TTM) | -0.09 | |||
| EPS Diluted Growth (Q YOY) | 39.88% | |||
| Balance Sheet | TVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.28M | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 2.36M | |||
| Total Preferred Equity (Q) | 8.80 | |||
| Total Equity (Q) | -6.67M | |||
| Current Ratio (Q) | 0.261 | |||
| Book Value Per Share (Q) | -$0.09 | |||
| Total Assets (Q) | 3.46M | |||
| Total Current Liabilities (Q) | 9.04M | |||
| Total Debt (Q) | 2.89M | |||
| Total Liabilities (Q) | 10.14M | |||
| Total Common Equity (Q) | -15.47M | |||
| Cash Flow | TVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 12.23M | |||
| Net Change in Cash (TTM) | 230.60K | |||
| Levered Free Cash Flow (TTM) | 8.82M | |||
| Cash from Operations (TTM) | -12.00M | |||
